Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Gastroenterology

Retrieve available abstracts of 172 articles:
HTML format

Single Articles

    April 2021
  1. CHENG CY, Wu J
    Erythematous plaques on legs and feet in a patient with hepatitis C.
    Gastroenterology. 2021 Apr 1. pii: S0016-5085(21)00587.

    February 2021
  2. SONNEVELD MJ, Gehring AJ, Janssen HLA
    Nucleic Acid Polymer Therapy for Hepatitis B Virus: Strong Hepatitis B Surface Antigen Decline But Many Unanswered Questions.
    Gastroenterology. 2021;160:966-967.

  3. LUO Z, Ji Y, Gao H, Gomes Dos Reis FC, et al
    CRIg(+) Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance.
    Gastroenterology. 2021;160:863-874.
    PubMed     Abstract available

    January 2021
  4. ROCKEY DC, Friedman SL
    Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
    Gastroenterology. 2021 Jan 30. pii: S0016-5085(21)00330.
    PubMed     Abstract available

  5. PAIK JM, Younossi Y, Henry L, Mishra A, et al
    Recent Trends in the Global Burden of Hepatitis B virus (HBV): 2007-2017.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00029.

    December 2020
  6. PLOSS A, Strick-Marchand H, Li W
    Animal models for hepatitis B: does the supply meet the demand?
    Gastroenterology. 2020 Dec 19. pii: S0016-5085(20)35568.

  7. MASSEY V, Parrish A, Argemi J, Moreno M, et al
    Gastroenterology. 2020 Dec 9. pii: S0016-5085(20)35542.
    PubMed     Abstract available

    November 2020
  8. CHANG KC, Tsai JH, Su TH
    A Mysterious Case of Jaundice After Development of Skin Vesicles.
    Gastroenterology. 2020;159:1669-1671.

    October 2020
  9. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
    AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
    PubMed     Abstract available

    September 2020
  10. WEN X, Liu S, Lu F
    The Influence of Different Types of Serum Cholesterol on the Prognosis of Hepatitis B Virus-Related Hepatocellular Patients Needs More Attention.
    Gastroenterology. 2020;159:1190-1191.

    August 2020
  11. ZOULIM F, Lenz O, Vandenbossche JJ, Talloen W, et al
    JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.
    Gastroenterology. 2020;159:521-533.
    PubMed     Abstract available

    July 2020
  12. LIEM KS, Gehring AJ, Janssen HLA
    Reply to Letter to the Editor: Stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B (GASTRO-D-19-02940).
    Gastroenterology. 2020 Jul 18. pii: S0016-5085(20)34960.

    June 2020
  13. DURANTEL D, Asselah T
    Nucleic Acid Polymers are Effective in Targeting Hepatitis B Surface Antigen, but More Trials Are Needed.
    Gastroenterology. 2020;158:2051-2054.

  14. BAZINET M, Pantea V, Placinta G, Moscalu I, et al
    Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naive to Nucleos(t)ide Therapy.
    Gastroenterology. 2020;158:2180-2194.
    PubMed     Abstract available

  15. MITCHELL T, Dolcet A, Lewis D
    Between a Lift and a Hard Place.
    Gastroenterology. 2020;158:2063-2065.

    May 2020
  16. LIAW YF
    Stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
    Gastroenterology. 2020 May 17. pii: S0016-5085(20)30672.

  17. KIM D, Konyn P, Cholankeril G, Wong RJ, et al
    Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30599.

  18. SINGAL AG, Parikh ND, Murphy CC
    Gastroenterology. 2020;158:1844.

  19. MICHLER T, Kosinska AD, Festag J, Bunse T, et al
    Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Gastroenterology. 2020;158:1762-1775.
    PubMed     Abstract available

    April 2020
  20. CARVAO J, Pereira VM, Jasmins L
    A case of unexplained cutaneous lesions, cholestatic hepatitis and non-cirrhotic portal hypertension in a female patient.
    Gastroenterology. 2020 Apr 16. pii: S0016-5085(20)30494.

  21. LE BERT N, Gill US, Hong M, Kunasegaran K, et al
    Effects of Hepatitis B Surface Antigen on Virus-specific and Global T Cells in Patients With Chronic HBV infection.
    Gastroenterology. 2020 Apr 14. pii: S0016-5085(20)30492.
    PubMed     Abstract available

  22. MATSUURA H, Kishida M, Shimizu W
    Right Upper Quadrant Pain With Positive Murphy's Sign in a 19-Year-Old Woman.
    Gastroenterology. 2020;158:e3-e4.

    March 2020
  23. EL-SERAG HB, Kanwal F, Feng Z, Marrero JA, et al
    Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings from Texas Hepatocellular Carcinoma Consortium Cohort.
    Gastroenterology. 2020 Mar 29. pii: S0016-5085(20)30403.

  24. KAMAL F, Khan MA
    Is tenofovir associated with lower risk of hepatocellular carcinoma in patients with chronic hepatitis B compared to entecavir?
    Gastroenterology. 2020 Mar 19. pii: S0016-5085(20)30373.

  25. LEE HA, Seo YS, Kim SU
    Risk of Hepatocellular Carcinoma with Tenofovir vs. Entecavir in Patients with Chronic Hepatitis B.
    Gastroenterology. 2020 Mar 19. pii: S0016-5085(20)30374.

  26. SALINAS E, Grakoui A
    Monkey in the Middle: Dynamics of Interspecies Antibody Responses.
    Gastroenterology. 2020;158:820-822.

    February 2020
  27. HOWELL DJ, Chan HL, Feld JJ, Hellard ME, et al
    Closing the stable door after the horse has bolted - should we be treating people with immune-tolerant chronic hepatitis B to prevent hepatocellular carcinoma?
    Gastroenterology. 2020 Feb 20. pii: S0016-5085(20)30238.

  28. GEHRKE N, Schattenberg JM
    Metabolic inflammation - a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30230.
    PubMed     Abstract available

    January 2020
  29. LO GH
    Did direct-acting antiviral therapy for hepatitis C virus infection really improve the survival of patients with hepatocellular carcinoma ?
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30102.

    December 2019
  30. CHEN F, Nagy K, Chavez D, Willis S, et al
    Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B cell-Based Vaccine Development.
    Gastroenterology. 2019 Dec 3. pii: S0016-5085(19)41871.
    PubMed     Abstract available

  31. LIEM KS, Gehring AJ, Feld JJ, Janssen HLA, et al
    Challenges with stopping long-term nucleos(t)ide analogue therapy in patients with chronic hepatitis B.
    Gastroenterology. 2019 Dec 3. pii: S0016-5085(19)41872.

  32. KAMBOJ AK, Bledsoe AC, Arora AS
    A Slow and Distended Stomach.
    Gastroenterology. 2019;157:1485-1486.

    November 2019
  33. LAMPERTICO P, Papatheodoridis GV
    Gastroenterology. 2019 Nov 7. pii: S0016-5085(19)41524.

    October 2019
  34. LAMPERTICO P, Colombo M
    Gastroenterology. 2019 Oct 14. pii: S0016-5085(19)41448.

  35. VERRIER ER, Majzoub K, Baumert TF
    Hepatitis D Virus Infection Revisited.
    Gastroenterology. 2019 Oct 3. pii: S0016-5085(19)41373.

  36. KIM D, Adejumo AC, Yoo ER, Iqbal U, et al
    Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
    Gastroenterology. 2019;157:1055-1066.
    PubMed     Abstract available

    September 2019
  37. CHEUK-FUNG YIP T, Wai-Sun Wong V, Lik-Yuen Chan H, Tse YK, et al
    Tenofovir is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.
    Gastroenterology. 2019 Sep 28. pii: S0016-5085(19)41367.
    PubMed     Abstract available

    August 2019
  38. TSENG TC, Liu CJ, Hsu CY, Hong CM, et al
    High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41248.
    PubMed     Abstract available

  39. LOK AS, Sulkowski MS, Kort JJ, Willner I, et al
    Efficacy of Glecaprevir and Pibrentasvir in Patients with Genotype 1 Hepatitis C Virus Infection with Treatment Failure after NS5A Inhibitor Plus Sofosbuvir Therapy.
    Gastroenterology. 2019 Aug 8. pii: S0016-5085(19)41199.
    PubMed     Abstract available

    Multi-omic Analyses Reveal Complex Interactions Between HCV and Hepatocytes Demonstrating That the Red Queen Is Up and Running.
    Gastroenterology. 2019;157:300-302.

    July 2019
  41. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma.
    Gastroenterology. 2019 Jul 30. pii: S0016-5085(19)41137.
    PubMed     Abstract available

  42. FAN W, Liu T, Chen W, Hammad S, et al
    ECM1 Prevents Activation of Transforming Growth Factor beta, Hepatic Stellate Cells, and Fibrogenesis in Mice.
    Gastroenterology. 2019 Jul 27. pii: S0016-5085(19)41133.
    PubMed     Abstract available

  43. IOANNOU GN, Beste LA, Green PK, Singal AG, et al
    Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores.
    Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41130.
    PubMed     Abstract available

  44. KANWAL F, Singal AG
    Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
    Gastroenterology. 2019;157:54-64.
    PubMed     Abstract available

  45. KUMAR S, Prenner S
    Dyspepsia and Increased Levels of Liver Enzymes in a 24-Year-Old Man.
    Gastroenterology. 2019;157:27-28.

  46. AZIZ K, Limzerwala JF, Sturmlechner I, Hurley E, et al
    Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
    Gastroenterology. 2019;157:210-226.
    PubMed     Abstract available

  47. MEIJER JM, van Dalen T, van der Wal B
    A Patient with Jaundice and Pruritus, Not the Usual Suspect?
    Gastroenterology. 2019;157:e8-e9.

    May 2019
  48. ZANDVAKILI I, Lloyd JW, Giridhar KV
    Hepatitis, Pancreatitis and Rash in a Patient With Chronic Lymphocytic Leukemia.
    Gastroenterology. 2019 May 30. pii: S0016-5085(19)40973.

  49. WING PAC, Jones M, Cheung M, DaSilva S, et al
    Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir.
    Gastroenterology. 2019 May 9. pii: S0016-5085(19)40865.
    PubMed     Abstract available

  50. WIDJAJA AA, Singh BK, Adami E, Viswanathan S, et al
    Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.
    Gastroenterology. 2019 May 8. pii: S0016-5085(19)40858.
    PubMed     Abstract available

  51. HASHASH JG, Ibrahim D, Rizk NA
    An Uncommon Cause of Fever and Altered Levels of Liver Enzymes.
    Gastroenterology. 2019;156:1574-1575.

  52. SUNG PS, Jung ES, Yoon SK
    A Fierce Battle in the Liver to Kill the Enemy From Gut.
    Gastroenterology. 2019;156:e4-e6.

    April 2019
  53. LOHMANN V, Bartenschlager R
    Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36726.

  54. LEE BP, Samur S, Dalgic OO, Bethea ED, et al
    Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients with Alcohol-Associated Hepatitis.
    Gastroenterology. 2019 Apr 15. pii: S0016-5085(19)35705.
    PubMed     Abstract available

  55. LO GH
    Therapy of hepatitis B: Is it really not associated with HBsAg seroclearance ?
    Gastroenterology. 2019 Apr 11. pii: S0016-5085(19)35691.

  56. LUPBERGER J, Croonenborghs T, Roca Suarez AA, Van Renne N, et al
    Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease Development.
    Gastroenterology. 2019 Apr 9. pii: S0016-5085(19)35670.
    PubMed     Abstract available

  57. YUEN MF, Gane EJ, Kim DJ, Weilert F, et al
    Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection.
    Gastroenterology. 2019;156:1392-1403.
    PubMed     Abstract available

    March 2019
  58. BONI C, Janssen H, Rossi M, Yoon SK, et al
    Combined GS-4774 and Tenofovir Therapy can Improve HBV-Specific T-Cell Responses in Patients with Chronic Hepatitis.
    Gastroenterology. 2019 Mar 28. pii: S0016-5085(19)34634.
    PubMed     Abstract available

  59. SINGAL AG, Lim JK, Kanwal F
    AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2019 Mar 13. pii: S0016-5085(19)33558.

  60. HAMDANE N, Juhling F, Crouchet E, El Saghire H, et al
    HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
    Gastroenterology. 2019 Mar 2. pii: S0016-5085(19)32506.
    PubMed     Abstract available

  61. LIANG S, Ma HY, Zhong Z, Dhar D, et al
    NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Gastroenterology. 2019;156:1156-1172.
    PubMed     Abstract available

    February 2019
  62. TORRES HA, Pundhir P, Mallet V
    Hepatitis C virus infection in patients with cancer: impact on clinical trial enrollment, selection of therapy, and prognosis.
    Gastroenterology. 2019 Feb 21. pii: S0016-5085(19)30435.

  63. CACOUB P
    Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30382.

  64. KARIMZADEH H, Kiraithe MM, Oberhardt V, Alizei ES, et al
    Mutations in Hepatitis D Virus Allow it to Escape Detection by CD8+ T Cells and Evolve at the Population Level.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(19)30366.
    PubMed     Abstract available

  65. THABUT D, Bureau C, Layese R, Bourcier V, et al
    Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(18)35303.
    PubMed     Abstract available

  66. ANDERSON RT, Lim SG, Mishra P, Josephson F, et al
    Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.
    Gastroenterology. 2019;156:529-533.

  67. YEO YH, Ho HJ, Yang HI, Tseng TC, et al
    Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.
    Gastroenterology. 2019;156:635-646.
    PubMed     Abstract available

    January 2019
  68. KEFALAKES H, Koh C, Sidney J, Amanakis G, et al
    Hepatitis D Virus-specific CD8(+) T Cells Have a Memory-like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30095.
    PubMed     Abstract available

  69. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30057.
    PubMed     Abstract available

  70. DUSHEIKO G, Wang B
    Hepatitis B Surface Antigen Loss: Too Little, Too Late and the Challenge for the Future.
    Gastroenterology. 2019 Jan 11. pii: S0016-5085(19)30036.

  71. SALEM G, Adhikari LJ
    Hepatitis C, and Cannot See!
    Gastroenterology. 2019 Jan 2. pii: S0016-5085(18)35432.

  72. LEE BP, Im GY, Lucey MR, Terrault NA, et al
    Gastroenterology. 2019;156:286-287.

  73. COFFIN CS, Zhou K, Terrault NA
    New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.
    Gastroenterology. 2019;156:355-368.
    PubMed     Abstract available

  74. GEHRING AJ, Protzer U
    Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
    Gastroenterology. 2019;156:325-337.
    PubMed     Abstract available

  75. MCNAUGHTON AL, D'Arienzo V, Ansari MA, Lumley SF, et al
    Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.
    Gastroenterology. 2019;156:384-399.
    PubMed     Abstract available

  76. XIA Y, Liang TJ
    Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection.
    Gastroenterology. 2019;156:311-324.
    PubMed     Abstract available

    December 2018
  77. VERGARA C, Thio CL, Johnson E, Kral AH, et al
    Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35421.
    PubMed     Abstract available

  78. LIANG TJ, Terrault N
    Viral Hepatitis and Hepatocellular Carcinoma.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35423.

  79. ALTER HJ, Chisari FV
    Is Elimination of Hepatitis B and C a Pipe Dream or Reality?
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35422.

    November 2018
  80. BUTT AA, Yan P, Shuaib A, Abou-Samra AB, et al
    Direct-acting Antiviral Therapy for HCV Infection is Associated with a Reduced Risk of Cardiovascular Disease Events.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35264.
    PubMed     Abstract available

  81. WARD JW, Hinman AR
    What is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Gastroenterology. 2018 Nov 1. pii: S0016-5085(18)35205.
    PubMed     Abstract available

  82. NAGAI S, Chau LC, Schilke RE, Safwan M, et al
    Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Gastroenterology. 2018;155:1451-1462.
    PubMed     Abstract available

    October 2018
  83. IOANNOU GN, Feld JJ
    What are the Benefits of a Sustained Virologic Response to Direct-acting Antiviral Therapy for HCV Infection?
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35166.
    PubMed     Abstract available

  84. KULIK L, El-Serag HB
    Epidemiology and Management of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35165.
    PubMed     Abstract available

  85. KOH C, Heller T, Glenn JS
    Pathogenesis of and New Therapies for Hepatitis D.
    Gastroenterology. 2018 Oct 18. pii: S0016-5085(18)35162.
    PubMed     Abstract available

  86. BAUMERT TF, Berg T, Lim JK, Nelson DR, et al
    Status of Direct-acting Antiviral Therapy for HCV Infection and Remaining Challenges.
    Gastroenterology. 2018 Oct 17. pii: S0016-5085(18)35155.
    PubMed     Abstract available

  87. DELTENRE P, Marot A, Moreno C
    Outcomes after early liver transplantation for patients with severe alcoholic hepatitis: Additional evidence from a meta-analysis.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35151.

  88. VISENTINI M, Fiorilli M, Casato M
    Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35150.

  89. SOLGA SF, Goldberg DS, Spacek LA, Forde KA, et al
    Comment on B Lee et al Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35153.

  90. O'BRIEN TR, Yang HI, Groover S, Jeng WJ, et al
    Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression.
    Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35083.
    PubMed     Abstract available

  91. KIM D, Li AA, Gadiparthi C, Khan MA, et al
    Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Gastroenterology. 2018;155:1154-1163.
    PubMed     Abstract available

  92. PERRY I, Patel D
    Hemoptysis: Call the Gastroenterologist?
    Gastroenterology. 2018;155:e1-e2.

    September 2018
  93. BAILEY JR, Barnes E, Cox AL
    Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.
    Gastroenterology. 2018 Sep 26. pii: S0016-5085(18)35035.
    PubMed     Abstract available

  94. REHERMANN B, Thimme R
    Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection.
    Gastroenterology. 2018 Sep 26. pii: S0016-5085(18)35037.
    PubMed     Abstract available

  95. HU J, Lin YY, Chen PJ, Watashi K, et al
    Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.
    Gastroenterology. 2018 Sep 19. pii: S0016-5085(18)35030.
    PubMed     Abstract available

  96. VYAS AK, Jindal A, Trehanpati N
    Ponder the Innate Immunity in Hepatitis B Infection.
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34759.

  97. LUO X, Li H, Ma L, Zhou J, et al
    Expression of STING Is Increased in Liver Tissues from Patients With NAFLD and Promotes Macrophage-mediated Hepatic Inflammation and Fibrosis in Mice.
    Gastroenterology. 2018 Sep 10. pii: S0016-5085(18)34959.
    PubMed     Abstract available

    Re: Sofosbuvir, Velpatasvir, and Ribavirin in HCV.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34936.

  99. PRABHU A, Chapman TP, Cobbold JFL
    A Rare Cause of Hepatitis.
    Gastroenterology. 2018 Sep 7. pii: S0016-5085(18)34944.

  100. BASSEGODA O, Sole C, Diaz A
    An unusual cause of acute severe hepatitis.
    Gastroenterology. 2018 Sep 7. pii: S0016-5085(18)34945.

    August 2018
  101. BOYER A, Park SB, de Boer Y, Li Q, et al
    TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34892.
    PubMed     Abstract available

  102. OJHA RP, MacDonald BR, Chu TC, Marcus JL, et al
    Potential Overestimation of Racial Disparities in Response to the 8-Week Ledipasvir/Sofosbuvir Regimen for Hepatitis C Virus Genotype 1 Infection.
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34876.

    July 2018
  103. LUNEMANN S, Schobel A, Kah J, Fittje P, et al
    Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.
    Gastroenterology. 2018 Jul 19. pii: S0016-5085(18)34785.
    PubMed     Abstract available

  104. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    PubMed     Abstract available

  105. KOH S, Kah J, Tham CYL, Yang N, et al
    Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
    Gastroenterology. 2018;155:180-193.
    PubMed     Abstract available

    June 2018
  106. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Abstract available

    May 2018
  107. LIAW YF, Jeng WJ, Ming-Ling
    Quantitative HBsAg Kinetics in Retreatment Decision for Off-therapy Hepatitis B Flare in HBeAg-Negative Patients.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30409.

  108. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.

  109. LOUVET A, Thursz MR, Kim DJ, Labreuche J, et al
    Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34495.
    PubMed     Abstract available

  110. MOORMAN AC, Xing J, Nelson NP
    Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus.
    Gastroenterology. 2018 May 3. pii: S0016-5085(18)34481.

    April 2018
  111. BONACCI M, Lens S, Marino Z, Londono MC, et al
    Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
    Gastroenterology. 2018 Apr 26. pii: S0016-5085(18)30485.
    PubMed     Abstract available

  112. CAO P, Yang A, Wang R, Xia X, et al
    Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30481.
    PubMed     Abstract available

  113. LEE BP, Mehta N, Platt L, Gurakar A, et al
    Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30442.
    PubMed     Abstract available

  114. CALVARUSO V, Cabibbo G, Cacciola I, Petta S, et al
    Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441.
    PubMed     Abstract available

  115. MORSE A, Barritt AS 4th, Jhaveri R
    Individual State Hepatitis C Data Supports Expanding Screening Beyond Baby Boomers to All Adults.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30304.

  116. SCOTT RA, Aithal GP, Francis ST, Irving WL, et al
    Pretreatment Lesions on Magnetic Resonance Imaging in Patients With Hepatitis C Virus Infection Diagnosed With Hepatocellular Carcinoma After Initiating Direct-Acting Antiviral Therapy.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30305.

    March 2018
  117. WANG X, Dong Q, Li Q, Li Y, et al
    Dysregulated Response of Follicular Helper T cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.
    Gastroenterology. 2018 Mar 12. pii: S0016-5085(18)30313.
    PubMed     Abstract available

  118. GRUNVOGEL O, Colasanti O, Lee JY, Kloss V, et al
    Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll Like Receptor 3 in Hepatocytes.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30309.
    PubMed     Abstract available

  119. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    PubMed     Abstract available

  120. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.

  121. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.

  122. MANDORFER M, Reiberger T, Peck-Radosavljevic M
    Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30150.

    February 2018
  123. PHAM LV, Ramirez S, Gottwein JM, Fahnoe U, et al
    HCV Genotype 6a Escape from and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30212.
    PubMed     Abstract available

  124. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Abstract available

  125. WANG Y, Chen G, Pan Q, Zhao J, et al
    Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
    Gastroenterology. 2018 Feb 9. pii: S0016-5085(18)30017.

  126. BOETTLER T, Thimme R
    Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection.
    Gastroenterology. 2018 Feb 7. pii: S0016-5085(18)30159.

  127. MA AT, Feld JJ
    Hepatitis B Reactivation With Hepatitis C Treatment: Bringing Some Clarity to the Black Box.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30161.

  128. SUSLOV A, Boldanova T, Wang X, Wieland S, et al
    Hepatitis B Virus Does Not Interfere with Innate Immune Responses in the Human Liver.
    Gastroenterology. 2018 Feb 2. pii: S0016-5085(18)30078.
    PubMed     Abstract available

  129. TAVIS JE, Lomonosova E
    NVR 3-778 Plus Pegylated Interferon-alpha Treatment for Chronic Hepatitis B Viral Infections: Could 1 + 1 = 3?
    Gastroenterology. 2018;154:481-482.

  130. KLUMPP K, Shimada T, Allweiss L, Volz T, et al
    Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Gastroenterology. 2018;154:652-662.
    PubMed     Abstract available

    January 2018
  131. MUTZ P, Metz P, Lempp FA, Bender S, et al
    HBV Bypasses the Innate Immune Response and Does not Protect HCV From Antiviral Activity of Interferon.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30112.
    PubMed     Abstract available

  132. AGHEMO A, Colombo M
    Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30100.

  133. YOSHIKAWA T, Ohana M, Fukuda A
    High fever after radiofrequency ablation of hepatocellular carcinoma.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30134.

  134. BONI C, Vecchi A, Rossi M, Laccabue D, et al
    TLR7 Agonist Increases Responses Of HBV-Specific T Cells And Natural Killer Cells In Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
    Gastroenterology. 2018 Jan 26. pii: S0016-5085(18)30072.
    PubMed     Abstract available

  135. MOORMAN AC, Xing J, Rupp LB, Gordon SC, et al
    Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
    Gastroenterology. 2018 Jan 19. pii: S0016-5085(17)36689.

    December 2017
  136. POURCET B, Zecchin M, Ferri L, Beauchamp J, et al
    Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity Of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36725.
    PubMed     Abstract available

  137. WU X, Dao Thi VL, Liu P, Takacs CN, et al
    Pan-Genotype Hepatitis E Virus Replication in Stem Cell-derived Hepatocellular Systems.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36303.
    PubMed     Abstract available

  138. GOTTWEIN JM, Pham LV, Mikkelsen LS, Ghanem L, et al
    Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape Variants.
    Gastroenterology. 2017 Dec 21. pii: S0016-5085(17)36720.
    PubMed     Abstract available

  139. CHOI YS, Jung MK, Lee J, Choi SJ, et al
    Tumor Necrosis Factor-producing T-regulatory Cells are Associated With Severe Liver Injury in Patients With Acute Hepatitis A.
    Gastroenterology. 2017 Dec 8. pii: S0016-5085(17)36685.
    PubMed     Abstract available

  140. DUSSEAUX M, Masse-Ranson G, Darche S, Ahodantin J, et al
    Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Gastroenterology. 2017;153:1647-1661.
    PubMed     Abstract available

    November 2017
  141. LIU CJ, Chuang WL, Sheen IS, Wang HY, et al
    Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36369.
    PubMed     Abstract available

  142. DEBING Y, Schmid MA, Neyts J
    New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay Stack.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36372.

  143. TREPO E, Goossens N, Fujiwara N, Song WM, et al
    Combination of Gene Expression Signature and Model for End-stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2017 Nov 17. pii: S0016-5085(17)36367.
    PubMed     Abstract available

  144. SHERMAN KE, Shah VH
    Viral Hepatitis: Knowledge and Treatments for HBV/HCV and Associated Transplantation and Neoplasia.
    Gastroenterology. 2017 Nov 14. pii: S0016-5085(17)36348.

  145. DIETZ J, Susser S, Vermehren J, Peiffer KH, et al
    Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 13. pii: S0016-5085(17)36353.
    PubMed     Abstract available

  146. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    PubMed     Abstract available

    October 2017
  147. RATTAY T, Dumont P, Heinzow HS, Hutton DW, et al
    Cost-effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
    Gastroenterology. 2017 Oct 23. pii: S0016-5085(17)36275.
    PubMed     Abstract available

  148. JOHN M, Metwally M, Mangia A, Romero-Gomez M, et al
    TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.
    Gastroenterology. 2017 Oct 6. pii: S0016-5085(17)36134.

    Liver MAIT Cells in Hepatitis C: Pathogenetic Role or Innocent Bystanders?
    Gastroenterology. 2017 Oct 4. pii: S0016-5085(17)36186.

    September 2017
  150. MONTPELLIER C, Wychowski C, Sayed IM, Meunier JC, et al
    Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
    Gastroenterology. 2017 Sep 25. pii: S0016-5085(17)36179.
    PubMed     Abstract available

  151. CHILDS-KEAN LM, Hong J
    Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35912.

    August 2017
  152. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.

  153. YU ML
    Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35886.

  154. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Abstract available

    July 2017
  155. MISHRA P, Florian J, Peter J, Vainorius M, et al
    Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35956.

  156. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Abstract available

  157. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    PubMed     Abstract available

    June 2017
  158. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Abstract available

  159. ENOMOTO M, Murakami Y, Kawada N
    Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35638.

  160. DE MARCO L, Pellicano R
    When to Search for Occult Infection After Eradication of Hepatitis C?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35601.

    May 2017
  161. KANWAL F, Bacon BR, Beste LA, Brill JV, et al
    Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
    Gastroenterology. 2017;152:1588-1598.

  162. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Abstract available

    April 2017
  163. LAIDLAW SM, Marukian S, Gilmore RH, Cashman SB, et al
    Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent from Interferons.
    Gastroenterology. 2017 Apr 26. pii: S0016-5085(17)35530.
    PubMed     Abstract available

  164. JACOBSON IM, Lawitz E, Gane EJ, Willems BE, et al
    Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35399.
    PubMed     Abstract available

    March 2017
  165. HOWELL J, Thompson AJ
    Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.

  166. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Abstract available

  167. MISHRA P, Chen M
    Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?
    Gastroenterology. 2017 Mar 18. pii: S0016-5085(17)30295.

    January 2017
  168. BESSE-PATIN A, Leveille M, Oropeza D, Nguyen BN, et al
    Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
    Gastroenterology. 2017;152:243-256.
    PubMed     Abstract available

    November 2016
  169. LI F, Kaffenberger B, Hart PA
    An Unusual Rash During Evaluation for Chronic Pancreatitis.
    Gastroenterology. 2016 Nov 25. pii: S0016-5085(16)34961.

  170. COLPITTS CC, Baumert TF
    SMAD about HCV cell entry and pathogenesis of liver disease.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35398.

    April 2016
  171. KOK KS, Wharton R, Rushbrook SM
    An Unexpected Cause of Pancreatitis.
    Gastroenterology. 2016 Apr 30. pii: S0016-5085(16)00172.

  172. BARRESI L, Ligresti D, Traina M
    A Challenging Diagnosis for a Biliary Stricture.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00215.

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.